logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-112. Frequency of use of primary drug of clients entering inpatient treatment, 2011 or most recent year available

Part (iii) New cannabis inpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n)Frequency unknown
Belgium8.36.314.670.8488
Bulgaria::50.050.020
Czech Republic8.716.727.047.612618
Denmark::20.080.0152
Germany16.917.542.123.5183:
Estonia::::::
Ireland117.43.538.440.717217
Greece16.014.026.044.0500
Spain::::::
France::::::
Italy::::::
Cyprus37.520.812.529.2240
Latvia::::::
Lithuania::::::
Luxembourg::::::
Hungary3.417.237.941.4290
Malta::::::
Netherlands7.70.76.684.9271141
Austria40.94.536.418.2225
Poland216.716.734.632.1781
Portugal::::::
Romania19.429.06.545.23123
Slovenia::::::
Slovakia3.614.341.141.1564
Finland23.17.738.530.8130
Sweden117.17.320.355.31232
United Kingdom3::::::
Croatia53.830.8:15.41318
Turkey4.810.411.373.523010
Norway::::::
Total12.610.123.553.81486249
 

Notes:

: Indicates data are not available

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(3) Data are from 1st of April 2010 to 31st March 2011.

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

Page last updated: Friday, 26 April 2013